Kratchmarov Radomir, Djeddi Sarah, Dunlap Garrett, He Wenqin, Jia Xiaojiong, Burk Caitlin M, Ryan Tessa, McGill Alanna, Allegretti Jessica R, Kataru Raghu P, Mehrara Babak J, Taylor Erin M, Agarwal Shailesh, Bhattacharyya Neil, Bergmark Regan W, Maxfield Alice Z, Lee Stella, Roditi Rachel, Dwyer Daniel F, Boyce Joshua A, Buchheit Kathleen M, Laidlaw Tanya M, Shreffler Wayne G, Rao Deepak A, Gutierrez-Arcelus Maria, Brennan Patrick J
Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Nat Immunol. 2024 May;25(5):902-915. doi: 10.1038/s41590-024-01803-2. Epub 2024 Apr 8.
Repetitive exposure to antigen in chronic infection and cancer drives T cell exhaustion, limiting adaptive immunity. In contrast, aberrant, sustained T cell responses can persist over decades in human allergic disease. To understand these divergent outcomes, we employed bioinformatic, immunophenotyping and functional approaches with human diseased tissues, identifying an abundant population of type 2 helper T (T2) cells with co-expression of TCF7 and LEF1, and features of chronic activation. These cells, which we termed T2-multipotent progenitors (T2-MPP) could self-renew and differentiate into cytokine-producing effector cells, regulatory T (T) cells and follicular helper T (T) cells. Single-cell T-cell-receptor lineage tracing confirmed lineage relationships between T2-MPP, T2 effectors, T cells and T cells. T2-MPP persisted despite in vivo IL-4 receptor blockade, while thymic stromal lymphopoietin (TSLP) drove selective expansion of progenitor cells and rendered them insensitive to glucocorticoid-induced apoptosis in vitro. Together, our data identify T2-MPP as an aberrant T cell population with the potential to sustain type 2 inflammation and support the paradigm that chronic T cell responses can be coordinated over time by progenitor cells.
在慢性感染和癌症中反复接触抗原会导致T细胞耗竭,限制适应性免疫。相比之下,异常的、持续的T细胞反应在人类过敏性疾病中可持续数十年。为了理解这些不同的结果,我们采用生物信息学、免疫表型分析和功能方法研究人类患病组织,鉴定出大量共表达TCF7和LEF1且具有慢性激活特征的2型辅助性T(T2)细胞。我们将这些细胞称为T2多能祖细胞(T2-MPP),它们能够自我更新并分化为产生细胞因子的效应细胞、调节性T(Treg)细胞和滤泡辅助性T(Tfh)细胞。单细胞T细胞受体谱系追踪证实了T2-MPP、T2效应细胞、Treg细胞和Tfh细胞之间的谱系关系。尽管体内进行了IL-4受体阻断,T2-MPP仍持续存在,而胸腺基质淋巴细胞生成素(TSLP)驱动祖细胞选择性扩增,并使其在体外对糖皮质激素诱导的凋亡不敏感。总之,我们的数据将T2-MPP鉴定为一种异常的T细胞群体,具有维持2型炎症的潜力,并支持慢性T细胞反应可由祖细胞随时间进行协调的范式。
Allergy Asthma Proc. 2011
Clin Exp Allergy. 2009-6
Sci Signal. 2018-3-13
J Allergy Clin Immunol. 2015-3
Nat Immunol. 2025-8
Cell Mol Immunol. 2025-7-10
Front Immunol. 2025-6-12
J Allergy Clin Immunol. 2025-5
Immunol Rev. 2025-3
Cells. 2024-11-23
J Allergy Clin Immunol. 2025-2
J Allergy Clin Immunol. 2023-8
Nat Rev Immunol. 2023-1